Recent Advances and Mechanisms of Phage-Based Therapies in Cancer Treatment
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25189938 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Vivian Y Ooi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Agricultural Biotechnology Laboratory, Auxergen Inc., Riti Rossi Colwell Center, 701 E Pratt Street, Baltimore, MD 21202, USA. Hauptthemen laut MEDLINE: Neoplasms, Phage Therapy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The increasing interest in bacteriophage technology has prompted its novel applications to treat different medical conditions, most interestingly cancer. Due to their high specificity, manipulability, nontoxicity, and nanosize nature, phages are promising carriers in targeted therapy and cancer immunotherapy. This approach is particularly timely, as current challenges in cancer research include damage to healthy cells, inefficiency in targeting, obstruction by biological barriers, and drug resistance. Some cancers are being kept at the forefront of phage research, such as colorectal cancer and HCC, while others like lymphoma, cervical cancer, and myeloma have not been retouched in a decade. Common mechanisms are immunogenic antigen display on phage coats and the use of phage as transporters to carry drugs, genes, and other molecules. To date, popular phage treatments being tested are gene therapy and phage-based vaccines using M13 and λ phage, with some vaccines having advanced to human clinical trials. The results from most of these studies have been promising, but limitations in phage-based therapies such as reticuloendothelial system clearance or diffusion inefficiency must be addressed. Before phage-based therapies for cancer can be successfully used in oncology practice, more in-depth research and support from local governments are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Agricultural Biotechnology Laboratory, Auxergen Inc., Riti Rossi Colwell Center, 701 E Pratt Street, Baltimore, MD 21202, USA.
ORCID-Profile: Ting-Yu Yeh
Zitieren
APA
Ooi, V. Y., & Yeh, T. Y. (2024). Recent Advances and Mechanisms of Phage-Based Therapies in Cancer Treatment. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25189938
Vancouver
Ooi VY, Yeh TY. Recent Advances and Mechanisms of Phage-Based Therapies in Cancer Treatment. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25189938
BibTeX
@article{Ooi2024,
author = {Ooi, Vivian Y and Yeh, Ting-Yu},
title = {Recent Advances and Mechanisms of Phage-Based Therapies in Cancer Treatment},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25189938}
}
EUVIMED